Supraventricular tachycardia AHA recommendations for Management of Orthodromic AVRT: Difference between revisions
Aysha Aslam (talk | contribs) (Created page with "__NOTOC__ {{Supraventricular tachycardia}} {{CMG}} {{AE}}{{AA}} ==Overview== ==Management of Orthodromic AVRT== ==References== {{Reflist|2}}") |
Aysha Aslam (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Management of Orthodromic AVRT== | ==Management of Orthodromic AVRT== | ||
===Acute Treatment of Orthodromic AVRT=== | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
|colspan="1" style="text-align:center; background:LightGreen"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.'''Vagal maneuvers are recommended for acute treatment in patients with orthodromic AVRT <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-R]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.'''Adenosine is beneficial for acute treatment in patients with orthodromic AVRT <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-R]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''3.'''Synchronized cardioversion should be performed for acute treatment in hemodynamically unstable patients with | |||
AVRT if vagal maneuvers or adenosine are ineffective or not feasible <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-NR]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''4.'''Synchronized cardioversion is recommended for acute treatment in hemodynamically stable patients with AVRT | |||
when pharmacological therapy is ineffective or contraindicated <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-NR]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''5.'''Synchronized cardioversion should be performed for acute treatment in hemodynamically unstable patients with | |||
pre-excited AF<nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-NR ]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''6.'''Ibutilide or intravenous procainamide is beneficial for acute treatment in patients with pre-excited AF | |||
who are hemodynamically stable <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
|colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | |||
|- | |||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''Intravenous diltiazem, verapamil <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-R]])'' or beta blockers can be effective for acute treatment in patients with orthodromic AVRT who do not have preexcitation | |||
on their resting ECG during sinus rhythm <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIb]] | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''Intravenous beta blockers, diltiazem, or verapamil might be considered for acute treatment in patients with orthodromic | |||
AVRT who have pre-excitation on their resting ECG and have not responded to other therapies<nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:B-R]])'' <nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
|colspan="1" style="text-align:center; background:LightCoral"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]](harm) | |||
|- | |||
|bgcolor="LightCoral"|<nowiki>"</nowiki>'''1.'''Intravenous digoxin, intravenous amiodarone, intravenous or oral beta blockers, diltiazem, and verapamil are | |||
potentially harmful for acute treatment in patients with pre-excited AF ( <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | |||
|- | |||
|} | |||
===Management of ongoing Orthodromic AVRT=== | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 16:16, 26 October 2016
|
Supraventricular tachycardia Microchapters |
|
Differentiating Among the Different Types of Supraventricular Tachycardia |
|---|
|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
|
Diagnosis |
|
Treatment |
|
2015 ACC/AHA Guideline Recommendations |
|
Case Studies |
|
Supraventricular tachycardia AHA recommendations for Management of Orthodromic AVRT On the Web |
|
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of Orthodromic AVRT |
|
FDA on Supraventricular tachycardia AHA recommendations for Management of Orthodromic AVRT |
|
CDC on Supraventricular tachycardia AHA recommendations for Management of Orthodromic AVRT |
|
Supraventricular tachycardia AHA recommendations for Management of Orthodromic AVRT in the news |
|
Blogs on Supraventricular tachycardia AHA recommendations for Management of Orthodromic AVRT |
|
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Management of Orthodromic AVRT
Acute Treatment of Orthodromic AVRT
| Class I |
| "1.Vagal maneuvers are recommended for acute treatment in patients with orthodromic AVRT "(Level of Evidence: B-R) " |
| "2.Adenosine is beneficial for acute treatment in patients with orthodromic AVRT "(Level of Evidence: B-R) " |
| "3.Synchronized cardioversion should be performed for acute treatment in hemodynamically unstable patients with
AVRT if vagal maneuvers or adenosine are ineffective or not feasible "(Level of Evidence: B-NR) " |
| "4.Synchronized cardioversion is recommended for acute treatment in hemodynamically stable patients with AVRT
when pharmacological therapy is ineffective or contraindicated "(Level of Evidence: B-NR) " |
| "5.Synchronized cardioversion should be performed for acute treatment in hemodynamically unstable patients with
pre-excited AF"(Level of Evidence: B-NR ) " |
| "6.Ibutilide or intravenous procainamide is beneficial for acute treatment in patients with pre-excited AF
who are hemodynamically stable "(Level of Evidence: C-LD) " |
| Class IIa |
| "1.Intravenous diltiazem, verapamil "(Level of Evidence: B-R) or beta blockers can be effective for acute treatment in patients with orthodromic AVRT who do not have preexcitation
on their resting ECG during sinus rhythm "(Level of Evidence: C-LD) " |
| Class IIb |
| "1.Intravenous beta blockers, diltiazem, or verapamil might be considered for acute treatment in patients with orthodromic
AVRT who have pre-excitation on their resting ECG and have not responded to other therapies"(Level of Evidence:B-R) " |
| Class III(harm) |
| "1.Intravenous digoxin, intravenous amiodarone, intravenous or oral beta blockers, diltiazem, and verapamil are
potentially harmful for acute treatment in patients with pre-excited AF ( "(Level of Evidence: C-LD) " |